Investment Rating - The investment rating for the company is "Buy (Maintain)" with a target price of 105.74 HKD [5][8]. Core Insights - The company is expected to see a significant increase in net profit attributable to shareholders, projected to grow by 91-93% [2]. - The company anticipates a doubling of revenue and net profit for 2025, with revenue expected to reach 24-24.5 billion CNY, representing a year-on-year growth of 98.3-102.5% [8]. - The company is expanding its offline store network and enhancing online channels, which is expected to drive overall operational capabilities [8]. - The introduction of new products, including a children's sunscreen, and partnerships aimed at transitioning to a "skin science company" are expected to enhance the product matrix [8]. Financial Forecasts - Revenue projections for the company are as follows: - 2023: 805 million CNY - 2024: 1,209.64 million CNY (growth of 50.27%) - 2025: 2,404.21 million CNY (growth of 98.75%) - 2026: 3,383.92 million CNY (growth of 40.75%) - 2027: 4,630.44 million CNY (growth of 36.84%) [4]. - Net profit attributable to shareholders is forecasted as: - 2023: 84.52 million CNY - 2024: 186.83 million CNY (growth of 121.06%) - 2025: 357.85 million CNY (growth of 91.53%) - 2026: 573.04 million CNY (growth of 60.14%) - 2027: 797.92 million CNY (growth of 39.24%) [4]. - The company maintains a high gross margin, projected to be around 82% over the forecast period [4]. Valuation Metrics - The company is currently valued at a P/E ratio of 115.48 for 2023, decreasing to 12.23 by 2027 [4]. - The P/B ratio is projected to decline from 20.76 in 2023 to 5.20 in 2027 [4]. - The target price of 105.74 HKD corresponds to a P/E valuation of 23 times for 2026 [8].
林清轩动态跟踪 —— 归母净利预增91-93%，看好高增持续